Cargando…
Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan
IMPORTANCE: Real-world evidence of SARS-CoV-2 transmission is needed to understand the prevalence of infection in the Japanese population. OBJECTIVE: To conduct sentinel screening of the Japanese population to determine the prevalence of SARS-CoV-2 infection in asymptomatic individuals, with complem...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856923/ https://www.ncbi.nlm.nih.gov/pubmed/36574249 http://dx.doi.org/10.1001/jamanetworkopen.2022.47704 |
_version_ | 1784873747769982976 |
---|---|
author | Suzuki, Toru Aizawa, Kenichi Shibuya, Kenji Yamanaka, Shinya Anzai, Yuichiro Kurokawa, Kiyoshi Nagai, Ryozo |
author_facet | Suzuki, Toru Aizawa, Kenichi Shibuya, Kenji Yamanaka, Shinya Anzai, Yuichiro Kurokawa, Kiyoshi Nagai, Ryozo |
author_sort | Suzuki, Toru |
collection | PubMed |
description | IMPORTANCE: Real-world evidence of SARS-CoV-2 transmission is needed to understand the prevalence of infection in the Japanese population. OBJECTIVE: To conduct sentinel screening of the Japanese population to determine the prevalence of SARS-CoV-2 infection in asymptomatic individuals, with complementary analysis for symptomatic patients as reported by active epidemiologic surveillance used by the government. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of a sentinel screening program investigated approximately 1 million asymptomatic individuals with polymerase chain reaction (PCR) testing for SARS-CoV-2 infection between February 22 and December 8, 2021. Participants included children, students, employed adults, and older individuals, as well as volunteers to broadly reflect the general Japanese population in the 14 prefectures of Japan that declared a state of emergency. Saliva samples and a cycle threshold (Ct) value of approximately 40 as standard in Japan were used. Polymerase chain reaction testing for symptomatic patients was separately done by public health authorities, and the results were obtained from the Ministry of Health, Labour, and Welfare of Japan to complement data on asymptomatic infections from the present study. MAIN OUTCOMES AND MEASURES: Temporal trends in positivity and prevalence (including surges of different variants) and demographic associations (eg, age, geographic location, and vaccination status) were assessed. RESULTS: The positive rate of SARS-CoV-2 infection in 1 082 976 asymptomatic individuals (52.08% males; mean [SD] age 39.4 [15.7] years) was 0.03% (95% CI, 0.02%-0.05%) during periods without surges and a maximum of 0.33% (95% CI, 0.25%-0.43%) during peak surges at the Japanese standard Ct value of approximately 40; however, the positive rate would have been 10-fold less at a Ct value of 25 as used elsewhere in the world (eg, UK). There was an increase in patients with a positive PCR test result with a Ct value of 25 or 30 preceding surges in infection and hotspots of asymptomatic infections. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of asymptomatic SARS-CoV-2 infection in the general population of Japan in 2021, as investigated by sentinel surveillance, a low rate of infection was seen in the Japanese population compared with reported levels elsewhere in the world. This finding provides real-world data on the state of infection in Japan. |
format | Online Article Text |
id | pubmed-9856923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-98569232023-02-03 Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan Suzuki, Toru Aizawa, Kenichi Shibuya, Kenji Yamanaka, Shinya Anzai, Yuichiro Kurokawa, Kiyoshi Nagai, Ryozo JAMA Netw Open Original Investigation IMPORTANCE: Real-world evidence of SARS-CoV-2 transmission is needed to understand the prevalence of infection in the Japanese population. OBJECTIVE: To conduct sentinel screening of the Japanese population to determine the prevalence of SARS-CoV-2 infection in asymptomatic individuals, with complementary analysis for symptomatic patients as reported by active epidemiologic surveillance used by the government. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of a sentinel screening program investigated approximately 1 million asymptomatic individuals with polymerase chain reaction (PCR) testing for SARS-CoV-2 infection between February 22 and December 8, 2021. Participants included children, students, employed adults, and older individuals, as well as volunteers to broadly reflect the general Japanese population in the 14 prefectures of Japan that declared a state of emergency. Saliva samples and a cycle threshold (Ct) value of approximately 40 as standard in Japan were used. Polymerase chain reaction testing for symptomatic patients was separately done by public health authorities, and the results were obtained from the Ministry of Health, Labour, and Welfare of Japan to complement data on asymptomatic infections from the present study. MAIN OUTCOMES AND MEASURES: Temporal trends in positivity and prevalence (including surges of different variants) and demographic associations (eg, age, geographic location, and vaccination status) were assessed. RESULTS: The positive rate of SARS-CoV-2 infection in 1 082 976 asymptomatic individuals (52.08% males; mean [SD] age 39.4 [15.7] years) was 0.03% (95% CI, 0.02%-0.05%) during periods without surges and a maximum of 0.33% (95% CI, 0.25%-0.43%) during peak surges at the Japanese standard Ct value of approximately 40; however, the positive rate would have been 10-fold less at a Ct value of 25 as used elsewhere in the world (eg, UK). There was an increase in patients with a positive PCR test result with a Ct value of 25 or 30 preceding surges in infection and hotspots of asymptomatic infections. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of asymptomatic SARS-CoV-2 infection in the general population of Japan in 2021, as investigated by sentinel surveillance, a low rate of infection was seen in the Japanese population compared with reported levels elsewhere in the world. This finding provides real-world data on the state of infection in Japan. American Medical Association 2022-12-27 /pmc/articles/PMC9856923/ /pubmed/36574249 http://dx.doi.org/10.1001/jamanetworkopen.2022.47704 Text en Copyright 2022 Suzuki T et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Suzuki, Toru Aizawa, Kenichi Shibuya, Kenji Yamanaka, Shinya Anzai, Yuichiro Kurokawa, Kiyoshi Nagai, Ryozo Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan |
title | Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan |
title_full | Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan |
title_fullStr | Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan |
title_full_unstemmed | Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan |
title_short | Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan |
title_sort | prevalence of asymptomatic sars-cov-2 infection in japan |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856923/ https://www.ncbi.nlm.nih.gov/pubmed/36574249 http://dx.doi.org/10.1001/jamanetworkopen.2022.47704 |
work_keys_str_mv | AT suzukitoru prevalenceofasymptomaticsarscov2infectioninjapan AT aizawakenichi prevalenceofasymptomaticsarscov2infectioninjapan AT shibuyakenji prevalenceofasymptomaticsarscov2infectioninjapan AT yamanakashinya prevalenceofasymptomaticsarscov2infectioninjapan AT anzaiyuichiro prevalenceofasymptomaticsarscov2infectioninjapan AT kurokawakiyoshi prevalenceofasymptomaticsarscov2infectioninjapan AT nagairyozo prevalenceofasymptomaticsarscov2infectioninjapan |